Identification and Functional Analysis of a Novel NSD2 Missense Variant in a Patient With Rauch‐Steindl Syndrome
Open Access
- 29 May 2026
- journal article
- case report
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 14 (6) , e70238
Abstract
Background: Rauch‐Steindl syndrome (RAUST) is a rare neurodevelopmental disorder caused by pathogenic variants in NSD2 , a histone methyltransferase gene at 4p16.3. Due to phenotypic overlap with Wolf‐Hirschhorn syndrome (WHS), RAUST is often misdiagnosed. Missense variants in NSD2 are particularly challenging to interpret without functional validation. Methods: Genomic DNA from the proband and her parents was extracted from peripheral blood. Trio‐whole‐exome sequencing (WES) was performed to identify candidate variants based on the clinical phenotype, followed by Sanger sequencing validation. RNA splicing impact was assessed via reverse transcription PCR and TA‐cloning from peripheral blood mononuclear cells. Results: A 7‐year‐8‐month‐old girl mainly presented with intrauterine and postnatal growth restriction, global developmental delay, intellectual disability, epilepsy, short stature, and facial dysmorphism was documented. Trio‐WES identified a novel de novo missense variant in NSD2 (NM_001042424.3: c.2137G>C, p.Gly713Arg), which is located at the last base of exon 11 and was predicted to be highly likely to cause aberrant splicing. Functional analysis revealed this variant causes exon 11 skipping in 53% of transcripts, resulting in a frameshift (p.Leu672Glyfs*20) and premature truncation. Conclusion: This is the first report of an NSD2 missense variant that functionally acts as a splicing mutation leading to protein truncation. Our findings highlight the necessity of RNA‐level functional assays for accurate variant interpretation and reinforce genotype–phenotype distinctions between RAUST and WHS.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFC2705202)
- Shanghai Municipal Health Commission (2024ZZ2005)
This publication has 24 references indexed in Scilit:
- Clinical details of individuals with Rauch–Steindl syndrome due to NSD2 truncating variantsMolecular Genetics & Genomic Medicine, 2024
- Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing SubgroupThe American Journal of Human Genetics, 2023
- H3K36me2 methyltransferase NSD2 orchestrates epigenetic reprogramming during spermatogenesisNucleic Acids Research, 2022
- Discovery of Small-Molecule Antagonists of the PWWP Domain of NSD2Journal of Medicinal Chemistry, 2021
- De novo loss-of-function variants in NSD2 (WHSC1) associate with a subset of Wolf–Hirschhorn syndromeCold Spring Harbor Molecular Case Studies, 2019
- Predicting Splicing from Primary Sequence with Deep LearningCell, 2019
- Developmental delay and failure to thrive associated with a loss‐of‐function variant in WHSC1 (NSD2)American Journal of Medical Genetics Part A, 2018
- REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense VariantsThe American Journal of Human Genetics, 2016
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Mapping the Wolf-Hirschhorn Syndrome Phenotype Outside the Currently Accepted WHS Critical Region and Defining a New Critical Region, WHSCR-2The American Journal of Human Genetics, 2003